Clever Carnivore
| Company type | Privately held company |
|---|---|
| Industry | Food technology |
| Founded | 2021 |
| Founders |
|
| Headquarters | |
| Website | clevercarnivore |
Clever Carnivore is an American food technology company headquartered in Chicago, Illinois, manufacturing cultivated pork, lamb, and beef. Founded in 2021, it is recognized as Chicago’s first cultivated meat startup. The company focuses on producing identical animal protein from animal cells, bypassing the need for traditional industrial farming and slaughter.
History
Clever Carnivore was co-founded in 2021 by Dr. Virginia Rangos, a sociologist from the University of Chicago, and Dr. Paul Burridge, an associate professor of pharmacology at Northwestern University and principal investigator of the Burridge Lab. Dr. Burridge is an industry leading expert in the fields of induced pluripotent stem cells and stem cell culture media formulations. He is best known for his published work on chemically defined and animal origin-free stem cell medias, significantly reducing the cost of stem cell research and eliminating the need the need for fetal bovine serum in producing cultivated meat.[1]
In August 2022, the company opened its first headquarters and laboratory in Chicago's Lincoln Park neighborhood. By December 2023, following an oversubscribed seed funding round, the company announced plans to expand into a larger facility equipped with 500-liter bioreactors and a test kitchen to scale production toward commercial viability.[2]
Low-Cost Cell Media
A primary barrier to the commercialization of cultivated meat is the high cost of the liquid nutrients (growth medium) required to grow cells. In June 2025, Clever Carnivore reported achieving a production cost for its food-grade media of $0.07 per liter, significantly lower than the industry standard of $1 to $10 per liter. The reduction marks an impressive milestone for cultivated meat and improves the potential to produce cultivated pork at a lower price than traditionally farmed pork.
Cell Line Development
The company utilizes unique, non-GMO porcine (pork) cell lines. These cells are highly proliferative, with reported doubling times of less than 14 hours. Unlike some competitors, Clever Carnivore emphasizes a non-genetically modified approach to improve consumer acceptance for its first generation of products.
Bioprocessing
Production occurs in a facility similar to a brewery. The company works directly with steel fabricators to design low-cost, large-scale bioreactors, aiming to minimize the capital expenditure (CapEx) required for commercial plants, a common pitfall of other cultivated meat companies. Clever Carnivore’s pilot facility currently contains 3 x 500L stainless steel, reusable bioreactors, as well as 2-10L benchtop scale reactors.
Products
The company is currently pursuing FDA authorization for its debut line of cultivated pork products, including bratwursts, breakfast sausages, and meatballs, with a target market entry as early as 2026. While pork is the lead product for regulatory approval, Clever Carnivore is also actively engaged in research and development (R&D) for cultivated beef and lamb to expand its future product portfolio.
Funding
As of late 2025, Clever Carnivore has raised approximately $10 million in total funding. Key investment rounds include:
Pre-Seed: $2.1 million (2022).
Seed Round: $7 million (December 2023), led by Lever VC, with participation from McWin Capital Partners, Thia Ventures, Valo Ventures, and Stray Dog Capital.[1]
References
- ^ a b Mridul, Anay (August 5, 2025). "Clever Carnivore Gives California A Taste of Its Lab-Grown Pork". Green Queen. Retrieved January 3, 2026.
- ^ Watson, Elaine (June 19, 2025). "Clever Carnivore's pragmatic path to cultivated meat profitability, starting with $0.07/liter media". AgFunderNews. Retrieved January 3, 2026.